Bayer Seen as Potential Buyer for Syngenta Seeds

Comments made by Bayer CEO Marijn Dekkers in a talk with the UK business newspaper Financial Times have fueled speculation that the German group may be interested in picking up the vegetable seeds business Swiss rival Syngenta plans to sell.

In a move market watchers thought was designed to pacify shareholders who had advocated a takeover by Monsanto, Syngenta put the business up for sale in September. The US group earlier withdrew its $46 billion hostile bid amid opposition from the Swiss group’s management.

At the time, Syngenta said its intent was to “accelerate shareholder value creation through unlocking the considerable inherent worth in its global seeds portfolio boost stock market value.”

Analysts placed the selling price in a corridor between $1.6 billion and $2.5 billion.

Questioned by Financial Times about Bayer’s plans for using the nearly €1.5 billion proceeds from the sale of shares in Covestro, the former MaterialScience, Dekkers suggested that – following recent high-end deals on the Healthcare side – a next move could be to bolster the CropScience arm.

Bayer would be a buyer rather than a seller in any further shake-up of global agricultural assets after the collapse of the Monsanto-Syngenta deal, Dekkers remarked.

“We are very committed to our crop science business and have no intention of selling it,” the CEO told the newspaper. “The question then becomes do you want to add to it? And I would say, yes, if there are appropriate opportunities we would be interested.”

Dekkers said there was also potential for bolt-on acquisitions in the animal health business.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.